Financial Snapshot
Revenues
Revenues
Revenue YoY Change
Revenues
Expenses
Cost Of Revenues
Gross Profit
Gross Profit Margin
Gross Profit
Selling, General & Admin Expense
Research & Development
Depreciation, Depletion & Amortization
SGA Expense to Gross Profit Ratio
R&D To Gross Profit Ratio
DDA To Gross Profit Ratio
Operating Expenses Total
Operating Profits/Loss
Operational Expenses
Interest Expenses
Interest Expenses To Operating Income %
Other Expense/Income
Interest & Other Expense/Income
Income/Loss
Pretax Income
Income Tax
Net Profits/Loss
Pretax Income YoY Change
Income Tax Rate
Net Profits/Loss YoY Change
Basic EPS
Net Income To Revenue Ratio
Pretax & Net Income
Assets & Liabilities
Cash & Short-Term Investments
Cash & Equivalents
Cash To Operating Expenses Ratio
Inventory
Receivables
Total Short-Term Assets
Property, Plant And Equipment
Long-Term Investments
Total Long-Term Assets
Total Assets
Net Income To Total Assets Percentage
Accounts Payable
Short-Term Debt
Long Term Debt Due
Total Short-Term Liabilities
Long-Term Debt
Other Long-Term Liabilities
Total Long-Term Liabilities
Total Liabilities
Short-Term To Long-Term Debt Ratio
Short-Term Assets To Debt Ratio
Long-Term Debt To Net Income Ratio
Assets & Liabilities
Ownership
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares
Stock Issuance & Repurchase
Ownership Data
Return On Shareholders' Equity
Book Value
Free Cash Flow
Free Cash Flow YoY
Free Cash Flow Margin
Dividends
Dividends
Stock Price
About ALR TECHNOLOGIES INC.
ALR Technologies, Inc. engages in the provision of remote monitoring and care facilitation for patients with diabetes. The company is headquartered in Richmond, Virginia and currently employs 6 full-time employees. The company went IPO on 2000-03-13. The firm has developed an approach to diabetes care that includes the United States Food and Drug Administration (FDA) cleared diabetes management system, which collects data directly from blood glucose meters (BGM); a patent-pending Predictive A1C algorithm to track treatment success between lab reports, and an FDA-cleared Insulin Dosing Adjustment program. The firm has developed the Diabetes Solution for human health and the GluCurve, a modified version of the Diabetes Solution for animal health (GluCurve) from its technology portfolio. Its platform provides healthcare professionals (HCPs) with patient prioritization reports and alerts based on the Predictive A1C measures and other related diagnostics. Predictive A1C was designed to assist HCPs in addressing clinical inertia in diabetes care. The firm's wholly owned subsidiaries include ALR Technologies SG Pte. Ltd. and Canada Diabetes Solution Centre Inc.
Industry: Communications Equipment, NEC Peers: ABBOTT LABORATORIES Acutus Medical, Inc. RemSleep Holdings Inc. DELCATH SYSTEMS, INC. STRATA Skin Sciences, Inc. ENDRA Life Sciences Inc. OMNIA WELLNESS INC. HeartBeam, Inc. MINERVA SURGICAL INC NeuroMetrix, Inc.
